Antiangiogenic treatment activity has been reported in solitary fibrous tumor (SFT), a rare
and little chemosensitive sarcoma. We explored the activity of sunitinib malate (SM) in SFT …

Background To report on sunitinib activity in a retrospective series of 35 solitary fibrous
tumor (SFT) treated at a single institution. Patients and methods From April 2008, 35 patients …

BACKGROUND Solitary fibrous tumors (SFTs) are soft tissue tumors of intermediate
malignancy that rarely metastasize. Although unresectable SFTs are reported to have a poor …

Simple Summary Solitary fibrous tumor (SFT) is a malignant condition that exhibits different
clinical behaviors ranging from low to high aggressive SFT, with dedifferentiated SFT (DD …

Abstract Background Solitary Fibrous Tumor is a rare type of soft tissue tumor of intermediate
malignant potential which may recur or metastasize in 15-20% of cases. Data on the …

Simple Summary In the latest WHO classification, solitary fibrous tumors (SFTs) are now
subdivided into benign SFT (intermediate category (locally aggressive)), SFT NOS …

Malignant solitary fibrous tumors are rare soft-tissue sarcomas. They are considered as low-
grade malignancies, but may display metastatic potential in 20% of the cases. In case of …

Objective: To investigate the efficacy and safety of pazopanib for recurrent or metastatic
solitary fibrous tumor (SFT) in first-and second-line settings. Methods: Patients histologically …

Background Patients with advanced solitary fibrous tumors (SFTs) have a poor prognosis;
treatment options for recurrent disease are particularly limited. Several novel targeted …

Background To explore the activity of pazopanib in solitary fibrous tumour (SFT). Patients
and methods In a preclinical study, we compared the activity of pazopanib, sorafenib …